A New Measure of Body Image in Eating Disorders

Measurement of Body Image in Eating Disorders

This study aims to compare a new electronic instrument called (here referred to as the 'Body App') with traditional paper and pencil rating scales for assessing how individuals with eating disorders evaluate their body image.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Self-perceived weight or shape disturbance is a core symptom of eating disorders, with heavy therapeutic and prognostic relevance. Developing a reliable and unbiased method to assess body image disturbance is imperative, as feature characteristics of eating disorders, such as anorexia nervosa, include the overestimation of body size and shape. Among the most essential features of the disorder, this inability to correctly judge one's own body image has been frequently linked to the maintenance of eating disorders. Moreover, persistent perceptual disturbance for one's visual appearance is one of the strong predictors of relapse in AN and bulimia nervosa.

Body image disturbance can be conceptualized as having two main components: perceptual, and attitudinal/affective. These might be considered two distinct constructs, best measured independently. However, clinicians currently rely upon self-report questionnaires that evaluate aggregates of symptoms, perceptual experiences, behaviors, and thoughts linked to the disorder. Some scales selectively evaluate body image characteristics such as body dissatisfaction and body distortion. However, it is unclear to what degree each of these measures quantifies the specific components of perceptual experiences vs. attitudinal/affective aspects. This study aims to evaluate whether a new electronic instrument, here referred to as the 'Body App', which separates estimations of body shape and size from the attitudinal/affective component might result in closer approximations of the perceptual component of weight or shape disturbance, and facilitate the assessment of body image disturbance in eating disorders.

Study Type

Interventional

Enrollment (Actual)

135

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oklahoma
      • Tulsa, Oklahoma, United States, 74133
        • Laureate Institute for Brain Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 64 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Eating disorders group:

Inclusion Criteria:

  • Primary clinical diagnosis of eating disorder
  • Receiving inpatient treatment for eating disorder
  • Body mass index greater than or equal to 14
  • Independently ambulatory
  • Possession of a smartphone with data plan
  • English proficiency

Exclusion Criteria:

  • Active suicidal ideation
  • Comorbid schizophrenia spectrum or other psychotic disorder.

Healthy comparison group:

Inclusion Criteria:

  • No current psychiatric diagnosis
  • Body mass index greater than or equal to 14
  • Independently ambulatory
  • Possession of a smartphone with data plan
  • English proficiency

Exclusion Criteria:

  • Body mass index > 41
  • Active suicidal ideation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Eating disorder
Measurement of body image via Body App and relationship to body measurement
Participants will indicate areas of concern on a virtual manikin using an electronic online interface. Body measurements will also be collected.
Other: Healthy comparison
Measurement of body image via Body App and relationship to body measurement
Participants will indicate areas of concern on a virtual manikin using an electronic online interface. Body measurements will also be collected.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body image distortion score on the Body App Tool
Time Frame: Through study completion, an average of 1 year
Discrepancy between subjective body estimation on avatar and actual measurement of corresponding body part
Through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body image dissatisfaction score on the Photographic Figure Rating Scale
Time Frame: Through study completion, an average of 1 year
Average of the absolute change in body image dissatisfaction across each measurement (score range: 0 to 10; larger changes indicate greater severity of body image dissatisfaction)
Through study completion, an average of 1 year
Body image disturbance on the Body Appreciation Scale-2
Time Frame: Through study completion, an average of 1 year
Average of the absolute change in body image disturbance across each measurement relative to baseline (range 10 to 50, higher scores indicating reduced severity of body image disturbance)
Through study completion, an average of 1 year
Eating disorder severity on the Eating Disorder Examination Questionnaire
Time Frame: Through study completion, an average of 1 year
Average of the absolute change in overall eating disorder severity across each measurement relative to baseline (range 0 to 6, larger scores indicate greater severity of eating disorder)
Through study completion, an average of 1 year
Body image disturbance on the Body Image States Scale
Time Frame: Through study completion, an average of 1 year
Average of the absolute change in body image disturbance across each measurement relative to baseline (range 0 to 48, higher scores indicate greater severity of body image disturbance)
Through study completion, an average of 1 year
Body dysmorphic concerns on the Dysmorphic Concerns Questionnaire
Time Frame: Through study completion, an average of 1 year
Average of the absolute change in dysmorphic concerns across each measurement relative to baseline (range 0 to 21, higher scores indicate greater severity of dysmorphic concerns)
Through study completion, an average of 1 year
Exercise addiction on the Exercise Addiction Inventory
Time Frame: Through study completion, an average of 1 year
Average of the absolute change in exercise addiction across each measurement relative to baseline (range 6 to 30, higher scores indicate greater severity of exercise addiction)
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sahib Khalsa, MD, PhD, Laureate Institute for Brain Research

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 16, 2018

Primary Completion (Actual)

August 30, 2022

Study Completion (Estimated)

November 30, 2024

Study Registration Dates

First Submitted

March 19, 2018

First Submitted That Met QC Criteria

November 27, 2018

First Posted (Actual)

November 29, 2018

Study Record Updates

Last Update Posted (Actual)

October 5, 2023

Last Update Submitted That Met QC Criteria

October 4, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2018-001-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eating Disorder

Clinical Trials on Body App

3
Subscribe